New York State Common Retirement Fund
GNMX

New York State Common Retirement Fund’s Aevi Genomic Medicine Inc GNMX Stock Holding History

New York State Common Retirement Fund’s Portfolio GNMX Stock Details GNMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-15,501
Closed -$29K – 3280
2017
Q1 		$29K Buy
15,501
+1
+0% +$5 ﹤0.01% 3100
2016
Q4 		$80K Hold
15,500
– – ﹤0.01% 3005
2016
Q3 		$86K Hold
15,500
– – ﹤0.01% 3021
2016
Q2 		$86K Hold
15,500
– – ﹤0.01% 3023
2016
Q1 		$68K Hold
15,500
– – ﹤0.01% 3010
2015
Q4 		$93K Hold
15,500
– – ﹤0.01% 3025
2015
Q3 		$121K Buy
15,500
+4,440
+40% +$34.4K ﹤0.01% 2978
2015
Q2 		$68K Buy
+11,060
New +$85.7K ﹤0.01% 3172

Other funds holding GNMX

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
ECM
Element Capital Management New York $1.05B AUM 5.05% 1-Year Est. Return

New York State Common Retirement Fund's GNMX Position: Q2 2017 in Review

New York State Common Retirement Fund sold out of Aevi Genomic Medicine Inc (GNMX) in Q2 2017, closing a stake of 15,501 shares — an estimated $29K sold.

New York State Common Retirement Fund first reported a position in GNMX in Q2 2015 and held it in 8 quarters. The position peaked at $121K in Q3 2015. 51 funds tracked by Wall St. Rank hold GNMX as of Q2 2017.

  • New York State Common Retirement Fund reported no remaining Aevi Genomic Medicine Inc position as of Q2 2017 after selling out during the quarter.
  • New York State Common Retirement Fund sold 15,501 Aevi Genomic Medicine Inc shares in Q2 2017, an estimated $29K.
  • New York State Common Retirement Fund first reported a position in Aevi Genomic Medicine Inc in Q2 2015 and held it in 8 quarters.
  • New York State Common Retirement Fund's Aevi Genomic Medicine Inc position peaked at $121K in Q3 2015.
  • 51 funds tracked by Wall St. Rank held Aevi Genomic Medicine Inc as of Q2 2017.

Based on New York State Common Retirement Fund's 13F filing for Q2 2017, filed 11 Aug 2017.